MENU
+Compare
GBIO
Stock ticker: NASDAQ
AS OF
Apr 29, 04:59 PM (EDT)
Price
$0.42
Change
-$0.01 (-2.33%)
Capitalization
28.91M

GBIO Generation Bio Co Forecast, Technical & Fundamental Analysis

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases... Show more

GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GBIO with price predictions
Apr 28, 2025

GBIO's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for GBIO moved out of oversold territory on April 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In of the 37 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on GBIO as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GBIO just turned positive on April 11, 2025. Looking at past instances where GBIO's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GBIO advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GBIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GBIO broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GBIO entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.335) is normal, around the industry mean (14.342). P/E Ratio (0.000) is within average values for comparable stocks, (64.236). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.830). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. P/S Ratio (1.445) is also within normal values, averaging (254.940).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GBIO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GBIO is expected to report earnings to fall 7.06% to -29 cents per share on May 01

Generation Bio Co GBIO Stock Earnings Reports
Q1'25
Est.
$-0.30
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.72
The last earnings report on March 13 showed earnings per share of -31 cents, missing the estimate of -30 cents. With 124.23K shares outstanding, the current market capitalization sits at 28.91M.
A.I. Advisor
published General Information

General Information

a genetic medicines company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
301 Binney Street
Phone
+1 617 655-7500
Employees
174
Web
https://www.generationbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

GBIO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ATOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+1.01%
ATOS - GBIO
50%
Loosely correlated
-1.77%
AURA - GBIO
48%
Loosely correlated
+2.42%
CCCC - GBIO
46%
Loosely correlated
+5.19%
ABOS - GBIO
46%
Loosely correlated
-4.63%
IDYA - GBIO
45%
Loosely correlated
+3.95%
More